Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 901 to 910 of 2519

TitleReference numberPublishedLast updated
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal)TA674
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)TA675
moorLDLS-BI for burn depth assessmentMIB251
The STAK tool for preventing and treating knee stiffnessMIB252
PROPEL sinus implants for maintaining sinus patency after surgeryMIB253
Trabectedin for the treatment of advanced soft tissue sarcomaTA185
URO17 for detecting bladder cancerMIB250
Mepolizumab for treating severe eosinophilic asthmaTA671
Brolucizumab for treating wet age-related macular degenerationTA672
Leukomed Sorbact for preventing surgical site infectionHTG567

Results per page

  1. 10
  2. 25
  3. 50
  4. All